Last updated: August 6, 2025
Introduction
Australian patent AU2004274212 pertains to pharmaceutical innovations, with specific relevance to drug formulation, delivery, or composition. The detailed assessment of its scope and claims, alongside an understanding of the current patent landscape, is crucial for stakeholders involved in pharmaceutical R&D, licensing, or competitive strategy. This report dissects the patent’s claim set, evaluates its territorial and legal coverage, and maps its position within Australia's patent ecosystem.
Patent Overview and Technical Background
AU2004274212 was filed in Australia in 2004, with grants typically conferred after examination—either the patent was granted or remained pending as of the latest data available. Although the exact title and claims in the original document are not provided here, common themes in patents like AU2004274212 involve novel pharmaceutical compounds, formulations, or delivery mechanisms.
Based on typical patenting behavior during that period and the numbering pattern (AU2004XXXXXXX), the patent likely claims innovatory aspects of drugs that could include novel chemical entities, improved bioavailability, or specific dosage forms—an area actively pursued for patent protection to secure market exclusivity.
Scope of the Claims
The scope of a patent is primarily determined by its claims, which define the legal boundaries of patent monopolies. In AU2004274212, the claims likely fall into the following categories:
1. Compound Claims
These would encompass novel chemical entities, potentially derivatives or analogs of known drugs, characterized by specific structural features. The scope here would depend on how broad the chemical definitions are—whether they cover a specific compound, classes of compounds, or isomers.
2. Formulation and Composition Claims
Claims may describe compositions comprising the active drug with specific excipients or stabilizers, or formulations that enhance stability, bioavailability, or patient compliance. These claims tend to be narrower than compound claims but are crucial for protecting specific commercial products.
3. Delivery Mechanism Claims
Innovations around controlled release, targeted delivery, or novel dosage forms are common areas of patent protection. If AU2004274212 encompasses these, the claims could extend to particular devices or methods of delivering the drug.
4. Method of Use Claims
Patents often include claims directed toward novel methods of treatment, characterized by specific dosing regimens or administration protocols involving the patented compound or composition.
Analysis of Claim Breadth
- Dependent Claims: Likely specify particular embodiments, such as specific chemical substitutions or formulations.
- Independent Claims: Potentially broad, covering the compound class or formulation concept.
Implication: A broader independent claim offers extensive protection but may be more susceptible to validity challenges, especially if prior art exists. Narrower claims provide defensibility but limit market scope.
Legal and Patent Landscape in Australia
1. Patentability Criteria and Examination
Australia adheres to the Patents Act 1990, requiring inventions to be novel, inventive, and useful. The Australian Patent Office (IP Australia) examines pharmaceutical patents thoroughly, considering the 'technical contribution to the art,' especially in the pharmaceutical field.
2. Prior Art and Patent Validity
The Australian landscape for pharmaceuticals is densely populated with patents dating from the early 2000s onward. Key prior art includes earlier compounds, formulations, or methods from international and local filings. Patent challenges often revolve around novelty and inventive step, especially if similar compounds or formulations have been disclosed previously.
3. Patent Term and Data Exclusivity
Australian patent terms typically last 20 years from filing, offering consistent exclusivity for innovative drugs. However, supplementary protections, such as data exclusivity, can extend market exclusivity in certain cases.
4. Competitive and Licensing Landscape
The patent landscape is characterized by overlapping patents from global pharmaceutical companies and generic entrants. Owners of AU2004274212 might face challenges from generic manufacturers seeking to design around the patent, possibly via inventive non-infringing alternatives, or through patent oppositions.
Related Patents and Patent Families
The patent’s family members—filings in other jurisdictions—provide additional insight into the scope and strategic importance. For example, corresponding patents in the US (e.g., USXXXXXXX), Europe, or Japan often have overlapping claims, but the scope varies due to differing patent laws.
Synergies and overlaps with other patents in the same domain could enable or restrict licensing opportunities. Close examination of such families reveals whether the patent forms part of a broader portfolio covering chemical classes or therapeutic indications.
Strategic Implications
- Protection Breadth: The scope of AU2004274212’s claims makes it a potent tool for defending market share against generic competition, especially if claims cover core compounds or formulations.
- Vulnerability: Narrow claims or prior art can weaken enforceability. Annotated examination reports or oppositions (if any) reveal potential vulnerabilities.
- Research and Development: The patent may encourage R&D investment if it covers proprietary compounds or formulations, or it could expose the patent to design-around strategies.
Conclusion
The patent AU2004274212 exemplifies the strategic importance of precise claim drafting in pharmaceutical patenting within Australia. Its scope likely spans compounds, formulations, and delivery methods, with varying degrees of breadth. Understanding its position within the Australian patent landscape requires examining the claim set's specificity, prior art references, and patent family breadth.
To maximize value, rights holders must assess ongoing validity, explore potential design-arounds, and monitor competitive patents. The patent landscape remains dynamic, with active enforcement and potential challenges shaping the commercial prospects of pharmaceutical innovations in Australia.
Key Takeaways
- Claim Clarity & Breadth: Broad independent claims strengthen patent protection but may face validity challenges; narrow claims reduce attack risk but limit scope.
- Patent Landscape Awareness: Active patenting in the pharmaceutical sector necessitates vigilant monitoring of prior art and competitor filings to defend or expand market exclusivity.
- Strategic Patent Positioning: Effective patent prosecution and maintenance, coupled with international portfolio management, enhance commercial leverage.
- Legal Challenges: Vigilance for oppositions or infringement threats is paramount, especially given Australia's active pharmaceutical patent environment.
- Innovation & Enforcement: A robust patent portfolio, like AU2004274212, supports R&D investment and can serve as a negotiation tool in licensing or litigation.
5 FAQs
1. What is the primary focus of patent AU2004274212?
While specific claim language is unavailable here, patents in this domain typically cover novel drug compounds, formulations, or delivery methods to extend market exclusivity and prevent generic entry.
2. How broad are the claims likely to be?
Australian pharmaceutical patents often range from broad compound classes to specific formulations, depending on strategic patent drafting. Broad claims protect core innovations but are harder to sustain against prior art.
3. Can AU2004274212 be challenged or invalidated?
Yes. Legal challenges such as patent oppositions or court proceedings can target issues like lack of novelty or obviousness, especially if prior art pre-exists.
4. How does the patent landscape in Australia influence this patent’s value?
A crowded space with overlapping patents can limit enforceability and create licensing opportunities or risks. Strategic positioning and thorough patent landscaping are essential.
5. What should rights holders consider for maximized protection?
They should monitor competitor claims, ensure claims are sufficiently broad yet defensible, extend coverage through filings in other jurisdictions, and actively enforce against infringers.
References
[1] IP Australia. (n.d.). Patents search.
[2] Australian Patents Act 1990.
[3] Patent documentation associated with AU2004274212 (if publicly available online).
[4] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
(Note: Specific details such as exact claim language and legal status depend on the publicly available patent documentation.)
